Evidence map›Paper›PMID 29029411›Full record

ArticleOncotarget2017

Nestin expression involves invasiveness of esophageal carcinoma and its downregulation enhances paclitaxel sensitivity to esophageal carcinoma cell apoptosis.

Jinghang Zhang, Jiateng Zhong, Jian Yu, Jinsong Li, Wenyu Di, Ping Lu, Xiaoyu Yang, Weixing Zhao, Xianwei Wang, Wei Su

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Oncotarget, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Jinghang ZhangDepartment of Pathology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, P.R. China.
Jiateng ZhongDepartment of Pathology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, P.R. China.
Jian YuDepartment of Pathology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, P.R. China.
Jinsong LiDepartment of Pathology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, P.R. China.
Wenyu DiDepartment of Pathology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, P.R. China.
Ping LuDepartment of Pathology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, P.R. China.
Xiaoyu YangDepartment of Pathology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, P.R. China.
Weixing ZhaoDepartment of Pathology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, P.R. China.
Xianwei WangHenan Key Laboratory of Medical Tissue Regeneration, Xinxiang Medical University, Xinxiang 453003, P.R. China.
Wei SuDepartment of Pathology, The First Affiliated Hospital of Xinxiang Medical University, Xinxiang 453003, P.R. China.
Xinxiang Medical University · CNFirst Affiliated Hospital of Xinxiang Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Paclitaxel has been generally used to treat primary and metastatic esophageal carcinoma. It has been shown that nestin is highly expressed in esophageal carcinoma and that there is a strong association of nestin expression with poor prognosis in esophageal carcinoma patients. In this study, using immunohistochemistry,

Indexed as

apoptosisesophageal carcinomametastasisnestinpaclitaxel

Identifiers

PMID29029411
PMCPMC5630311
OpenAlexW2612094726

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.